Flughafen Zürich AG (SWX:FHZN)

Verve Therapeutics Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,190	6,680	5,391	4,393	5,038	4,792
Market Cap Growth	23.90%	23.90%	22.71%	-12.79%	5.12%	-11.66%
Enterprise Value	8,307	7,845	6,498	5,818	6,342	5,937
Last Close Price	234.20	211.61	166.09	132.63	152.10	144.68
PE Ratio	22.01	20.45	17.72	21.22	-	-
Forward PE	22.64	19.63	17.41	21.14	39.38	127.24
PS Ratio	5.42	5.04	4.36	4.29	7.41	7.68
PB Ratio	2.42	2.25	1.92	1.64	2.09	2.05
P/TBV Ratio	2.80	2.60	2.20	1.89	2.45	2.43
P/FCF Ratio	43.52	40.43	18.06	14.23	64.67	-
P/OCF Ratio	11.21	10.41	7.92	8.99	21.74	32.53
PEG Ratio	16.89	46.08	46.08	46.08	38.61	26.75
EV/Sales Ratio	6.26	5.92	5.26	5.68	9.33	9.52
EV/EBITDA Ratio	11.32	10.82	9.71	10.62	21.67	31.63
EV/EBIT Ratio	18.85	17.80	16.65	22.01	339.12	-
EV/FCF Ratio	50.29	47.49	21.77	18.84	81.41	-
Debt / Equity Ratio	0.50	0.50	0.56	0.72	0.77	0.82
Debt / EBITDA Ratio	2.02	2.02	2.31	3.44	6.15	9.73
Debt / FCF Ratio	8.96	8.96	5.25	6.20	23.68	-
Asset Turnover	0.26	0.26	0.24	0.20	0.14	0.13
Inventory Turnover	24.34	24.34	29.31	35.19	27.08	28.11
Quick Ratio	1.67	1.67	1.31	1.36	3.23	2.49
Current Ratio	2.18	2.18	1.59	1.66	3.67	2.78
Return on Equity (ROE)	11.32%	11.32%	11.10%	8.13%	-0.43%	-2.88%
Return on Assets (ROA)	5.34%	5.34%	4.73%	3.25%	0.23%	-0.73%
Return on Capital (ROIC)	6.25%	6.25%	5.44%	3.73%	0.27%	-0.89%
Return on Capital Employed (ROCE)	9.10%	9.10%	8.70%	5.80%	0.40%	-
Earnings Yield	4.54%	4.89%	5.64%	4.71%	-0.20%	-1.44%
FCF Yield	2.30%	2.47%	5.54%	7.03%	1.55%	-1.77%
Dividend Yield	2.43%	2.69%	3.19%	1.81%	-	-
Payout Ratio	37.59%	37.59%	24.23%	-	-	-
Buyback Yield / Dilution	0.01%	0.01%	0.01%	-0.01%	-0.01%	-0.01%
Total Shareholder Return	2.49%	2.70%	3.20%	1.80%	-0.01%	-0.01%

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.